Our Bridging Study Experience

Richmond Pharmacology Ltd has successfully conducted Japanese bridging studies since 2001. Our team has completed in excess of 50 studies in Japanese subjects to date. Our study experience includes First-In-Japanese, Single-Dose, Single-Ascending Dose, Multiple Dose, Multiple-Ascending Dose and combined Single and Multiple Dose protocols. All these studies have required a different in-house period, a variety of study designs and different Japanese populations; all managed by your expert Richmond Pharmacology Japanese Study Team. 


Our unique and successful approach to volunteer advertising and recruitment has ensured that we are able to recruit a variety of Japanese volunteer populations to meet your needs.

Examples of our Bridging Studies in Japanese subjects in the last 2 years

Study Drug	No. of Subjects	Study Type	No.of nights
Sleep disorder	48	Double blind	17 nights + 2 outpatients
Atheroscleorsis	80	Double blind	3 nights x 9 outpatients
GERD	30	Double blind	3 nights x 2
Obesity	36	Double blind	4 nights + 3 outpatient x 2
Over active bladder symdrome	20	Double blind	3 nights x 4
TypeII Diabetes	36	Double blind	3 nights x 4
Alzheimer's disease	48	Double blind	8 nights
Neuropathic Pain	32	Double blind	3 nights
Major Depressive Disorder	36	Open-label	17 nights + 5 outpatients